CTA
DGX icon

Colonial Trust Advisors’s Quest Diagnostics DGX Stock Holding History

Colonial Trust Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.04M Sell
15,509
-217
-1% -$42.2K 0.24% 85
2025
Q4 		$2.73M Sell
15,726
-839
-5% -$153K 0.21% 88
2025
Q3 		$3.16M Sell
16,565
-853
-5% -$151K 0.24% 84
2025
Q2 		$3.13M Sell
17,418
-233
-1% -$40.5K 0.26% 81
2025
Q1 		$2.99M Sell
17,651
-719
-4% -$118K 0.27% 83
2024
Q4 		$2.77M Sell
18,370
-782
-4% -$122K 0.25% 85
2024
Q3 		$2.97M Sell
19,152
-691
-3% -$103K 0.26% 85
2024
Q2 		$2.72M Sell
19,843
-887
-4% -$121K 0.26% 84
2024
Q1 		$2.76M Sell
20,730
-663
-3% -$86K 0.27% 81
2023
Q4 		$2.95M Sell
21,393
-1,902
-8% -$250K 0.31% 77
2023
Q3 		$2.84M Sell
23,295
-1,799
-7% -$240K 0.33% 72
2023
Q2 		$3.53M Sell
25,094
-606
-2% -$83.5K 0.39% 64
2023
Q1 		$3.64M Sell
25,700
-1,524
-6% -$218K 0.43% 62
2022
Q4 		$4.26M Buy
27,224
+117
+0.4% +$16.8K 0.52% 61
2022
Q3 		$3.33M Buy
27,107
+89
+0.3% +$11.7K 0.45% 60
2022
Q2 		$3.59M Sell
27,018
-608
-2% -$82.8K 0.51% 57
2022
Q1 		$3.78M Sell
27,626
-449
-2% -$62.6K 0.45% 61
2021
Q4 		$4.86M Sell
28,075
-200
-0.7% -$30.4K 0.54% 54
2021
Q3 		$4.11M Sell
28,275
-525
-2% -$76.8K 0.51% 56
2021
Q2 		$3.8M Sell
28,800
-741
-3% -$97K 0.46% 60
2021
Q1 		$3.79M Buy
29,541
+250
+0.9% +$30.8K 0.5% 61
2020
Q4 		$3.49M Buy
29,291
+100
+0.3% +$12.2K 0.48% 61
2020
Q3 		$3.34M Sell
29,191
-450
-2% -$53.2K 0.53% 57
2020
Q2 		$3.38M Buy
29,641
+800
+3% +$84.9K 0.58% 56
2020
Q1 		$2.32M Buy
28,841
+475
+2% +$49.2K 0.48% 57
2019
Q4 		$3.03M Sell
28,366
-975
-3% -$102K 0.5% 57
2019
Q3 		$3.14M Sell
29,341
-50
-0.2% -$5.13K 0.56% 57
2019
Q2 		$2.99M Sell
29,391
-1,265
-4% -$122K 0.54% 58
2019
Q1 		$2.76M Buy
30,656
+1,700
+6% +$147K 0.52% 58
2018
Q4 		$2.41M Sell
28,956
-36,275
-56% -$3.4M 0.59% 56
2018
Q3 		$7.04M Sell
65,231
-3,655
-5% -$401K 1.32% 24
2018
Q2 		$7.57M Sell
68,886
-308
-0.4% -$32.1K 1.5% 22
2018
Q1 		$6.94M Sell
69,194
-21,450
-24% -$2.2M 1.41% 22
2017
Q4 		$8.93M Buy
90,644
+21,806
+32% +$2.07M 1.38% 25
2017
Q3 		$6.45M Sell
68,838
-272
-0.4% -$28.9K 1.42% 21
2017
Q2 		$7.68M Buy
69,110
+15,298
+28% +$1.62M 1.74% 17
2017
Q1 		$5.78M Buy
53,812
+124
+0.2% +$11.8K 1.78% 16
2016
Q4 		$4.93M Sell
53,688
-374
-0.7% -$32.2K 1.59% 22
2016
Q3 		$4.58M Buy
54,062
+1,076
+2% +$90.4K 1.44% 23
2016
Q2 		$4.31M Buy
52,986
+2,211
+4% +$168K 1.38% 24
2016
Q1 		$3.63M Buy
+50,775
New +$3.41M 1.18% 25

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Colonial Trust Advisors's DGX Position: Q1 2026 in Review

Colonial Trust Advisors reduced its Quest Diagnostics (DGX) stake by 1.4% in Q1 2026, selling an estimated $42.2K and leaving 15,509 shares worth $3.04M. The position accounts for 0.24% of the portfolio, ranked #85.

Colonial Trust Advisors first reported a position in DGX in Q1 2016 and has held it in 41 quarters since. The position peaked at $8.93M in Q4 2017. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Colonial Trust Advisors held 15,509 shares of Quest Diagnostics worth $3.04M as of Q1 2026.
  • Colonial Trust Advisors sold 217 Quest Diagnostics shares in Q1 2026, an estimated $42.2K.
  • Quest Diagnostics made up 0.24% of Colonial Trust Advisors's portfolio in Q1 2026, its #85 holding.
  • Colonial Trust Advisors first reported a position in Quest Diagnostics in Q1 2016 and has held it in 41 quarters since.
  • Colonial Trust Advisors's Quest Diagnostics position peaked at $8.93M in Q4 2017.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.